The importante of profilaxis in venous thromboembolism

Article Sidebar

PDF (Português (Brasil)) PDF
Published: Nov 24, 2020
DOI: https://doi.org/10.21876/rcshci.v10i4.1070
Keywords:
venous thromboembolism, disease prevention

Main Article Content

Marcelo Calil Burihan
Santa Marcelina Hospital. Faculty Santa Marcelina. Sao Paulo, Sao Paulo, Brazil.

Abstract

During the coronavirus pandemic, there has been much discussion worldwide about the prophylaxis of venous thromboembolism (VTE) in hospitalized patients or not. After the pandemic is over or minimized, we must keep this in mind as one of the most critical tasks to be done, during and after hospitalization, regardless of the case.

Article Details

How to Cite
1.
Burihan MC. The importante of profilaxis in venous thromboembolism. HSJ [Internet]. 2020Nov.24 [cited 2024Jul.3];10(4):1-. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1070
Issue
Vol 10 No 4 (2020): October to December 2020
Section
EDITORIAL
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International , allowing their sharing, recognizing the authorship and initial publication in this journal.

Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.

Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.

Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.

Author Biography

Marcelo Calil Burihan, Santa Marcelina Hospital. Faculty Santa Marcelina. Sao Paulo, Sao Paulo, Brazil.

Professor at the Faculty of Medicine Santa Marcelina (FASM). Coordinator of the Surgical Module and Preceptor of Medical Residency in Vascular Surgery at Hospital Santa Marcelina. Titular Member of the Brazilian Society of Angiology and Vascular Surgery (SBACV). Master from the Paulista School of Medicine of the Federal University of São Paulo (EPM / Unifesp). Director of publications at SBACV (2020-2021). Former president of SBACV-SP (2018-2019). Member of the Society for Vascular Surgery (SVS).

References

1. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3-14. https://doi.org/10.1007/s11239-015-1311-6 PMid:26780736 PMCid:PMC4715842
2. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167(14):1471-75. https://doi.org/10.1001/archinte.167.14.1471 PMid:17646600 PMCid:PMC2762787
3. Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res. 2016;137:3-10. https://doi.org/10.1016/j.thromres.2015.11.033 PMid:26654719 PMCid:PMC4706477
4. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756-64. https://doi.org/10.1160/TH07-03-0212 PMid:17938798
5. International Society on Thrombosis and Haemostasis [Internet]. Open your eyes to venous thromboembolism. [cited 2020 Nov 10] Avaiable from: https://www.worldthrombosisday.org/issue/vte/
6. Matchar DB, Mark DB. Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):132S-140S. https://doi.org/10.1378/chest.08-0671 PMid:18574263
7. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-94. Erratum in: Lancet. 2008;371(9628):1914. PMID: 18242412. https://doi.org/10.1016/S0140-6736(08)60202-0
8. NICE guideline [NG89]. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism [Internet]. London, UK: National Institute for Health and Care Excellence; 2018 Mar 21 [updated 2019 Aug 13; cited 2020 Nov 10]. Avaiable from: https://www.nice.org.uk/guidance/ng89
9. Kessler CM. The link between cancer and venous thromboembolism: a review. Am J Clin Oncol. 2009;32(4 Suppl):S3-7. https://doi.org/10.1097/coc.0b013e3181b01b17 PMID: 19654481.
10. Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, et al.; CAT-prediction collaborators. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica. 2019;104(6):1277-87. https://doi.org/10.3324/haematol.2018.209114 PMid:30606788 PMCid:PMC6545838
11. Farge D, Bounameaux H, Brenner B, et al. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Lancet Oncol. 2016;17:e452-66. https://doi.org/10.1016/S1470-2045(16)30369-2